Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
LE.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LE.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LE.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LF.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LF.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LF.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LF.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
MD.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
MD.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
MD.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MD.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LP.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LP.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LP.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LP.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.29.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.29.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.29.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.29.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.2.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.2.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.2.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.24.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.24.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.24.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
JN.1.24.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.18.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.18.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.18.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.18.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LU.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LU.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LU.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LU.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.40ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.40ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used